SHARE
COPY LINK

VACCINE

‘We must think ahead’: Norway mulls plan to vaccinate children

The Norwegian Institute of Public Health (NIPH) said that it may be "relevant" to vaccinate children as several vaccine manufacturers are currently testing their vaccines on youngsters.

'We must think ahead': Norway mulls plan to vaccinate children
(Photo by Miguel MEDINA / AFP)

“The infection has increased among children and young people with these new virus variants. And it (the pandemic) is not completely over even when everyone over the age of 18 has been vaccinated. And we must think ahead as well, whether it will be relevant to vaccinate children,” specialist director at the NIPH, Frode Forland, told state broadcaster NRK.

“Now the vaccines must first be tested among children and young people. And that’s about to happen now,” he added.

Why it might be important for children to be vaccinated

Margrethe Greve-Isdahl is the chief physician at the department of infection control and vaccines at the NIPH. She says vaccinating children can be important for two reasons.

“One is for children with a higher risk of serious Covid-19 disease. The second reason is that vaccination may be necessary to create herd immunity in the population,” she said.

“To say something certain about this, you need a better overview of how good the vaccines have on the spread of infection. In addition, vaccination coverage in the rest of the population will also play a role”, said Greve-Isdahl.

Is it safe?

Several vaccine companies are currently testing their vaccines on children to find out whether they are safe for use.

Pfizer will apply for approval for use of the vaccine in the United States for those over 12.  The company says the vaccine could be used on children in the autumn.

Moderna and AstraZeneca, which is currently paused in Norway, are testing vaccines on children and Johnson & Johnson is planning to test its Jansen single dose vaccine on children too.

So far none of these vaccines have been approved for use in children under 16 anywhere. Vaccines in Norway are only approved for people over 18.

Greve-Isdahl believes that, based on evidence from other existing vaccines, children can receive the same vaccines as adults, but in a different dosage.

“It is very important to look at the studies that are being done now, precisely to clarify this side effect profile. Here we just have to wait for data to come,” she said.

When could children begin getting vaccinated in Norway?

Espen Nakstad, assistant director at the Norwegian Directorate of Health, told newspaper Dagbladet that vaccines won’t be used on children in Norway until after the summer, at least.

Before being used on children in Norway, the vaccines will also need to apply for approval from the European Medicines Agency before the Norwegian Medicines Agency agrees to the use of vaccines on children.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS